A Multicenter, Post Marketing Clinical Follow up (PMCF) Investigation to Evaluate the Performance and Safety of a Soft Silicone Foam Dressing and to Evaluate the Performance of Standard Care in Exuding Venous Leg Ulcers

Inclusion criteria

• Venous Leg Ulcer
• Exuding wound
• Wound surface covered with sloughy tissue* (before debridement)
• Wound size ≥ 6 cm2
• In case of multiple wounds, target wound must be ≥ 3cm distant from other wounds.
• Wound suitable for treatment with the relevant primary dressing**
• Male or female, 18 years of age and above
• Signed Informed Consent

• Sloughy tissue defined as wet, yellow-brown fibrinous tissue present in the wound bed ** Mepilex XT in the intervention group. Standard care in the observation group

Exclusion criteria

• More than two products of 15 cm x15 cm needed to cover the whole wound and affected peri-wound area
• Wound cavity and/or fistula
• Full thickness burns
• Exposed tendons and/or fascia
• Bleeding wounds
• Malignant or fungating wounds
• Wound age > 12 months
• Use of antimicrobial dressings or topical agents such as antiseptics, local antibiotics and steroids within 7 days from inclusion on the wound intended to be included
• Untreated limb ischemia (according to investigator's judgement) at the time of inclusion
• Subject not suitable for the investigation according to the investigator's judgement
• Subject included in other ongoing clinical investigation which could interfere with this investigation, as judged by the investigator
• Known allergy/hypersensitivity to any of the components of the primary dressing